MULTILAC Trademark

Trademark Overview

On Wednesday, September 6, 2006, a trademark application was filed for MULTILAC with the United States Patent and Trademark Office. The USPTO has given the MULTILAC trademark a serial number of 79030841. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 7, 2016. This trademark is owned by Fresenius Medical Care Deutschland GmbH. The MULTILAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical solutions used in renal replacement therapies, namely, hemodialysis and hemofiltrations solutions
multilac

General Information

Serial Number79030841
Word MarkMULTILAC
Filing DateWednesday, September 6, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 7, 2016
Registration Number3356605
Registration DateTuesday, December 18, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2007

Trademark Statements

Goods and ServicesPharmaceutical solutions used in renal replacement therapies, namely, hemodialysis and hemofiltrations solutions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 25, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFresenius Medical Care Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameFresenius Medical Care Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameFresenius Medical Care Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, March 24, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 24, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, July 31, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, July 15, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, July 15, 2015INVALIDATION PROCESSED
Wednesday, March 25, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 25, 2014CANCELLED SECTION 71
Friday, April 1, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 11, 2008LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, September 11, 2008LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, April 8, 2008FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 8, 2008FINAL DISPOSITION PROCESSED
Monday, March 24, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, November 8, 2007CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, October 2, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 12, 2007NOTICE OF PUBLICATION
Tuesday, August 28, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 28, 2007ASSIGNED TO LIE
Tuesday, July 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 16, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 16, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2007REFUSAL PROCESSED BY IB
Monday, February 5, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 5, 2007REFUSAL PROCESSED BY MPU
Saturday, February 3, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 2, 2007NON-FINAL ACTION WRITTEN
Monday, January 29, 2007ASSIGNED TO EXAMINER
Friday, December 1, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, November 30, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

multilac solutions namely hemodialysis hemofiltrations therapies replacement used renal pharmaceutical